Health Care & Life Sciences » Biotechnology | NewLink Genetics Corp.

NewLink Genetics Corp.

NewLink Genetics Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.21 M
Public Float
28.83 M
NewLink Genetics Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.22
Market Cap
$54.42 M
Shares Outstanding
37.28 M
Public Float
28.76 M

Profile

Address
2503 South Loop Drive
Ames Iowa 50010
United States
Employees -
Website http://www.newlinkgenetics.com
Updated 07/08/2019
NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications.

Financials

View All

Charles J. Link
Chairman, Chief Executive & Scientific Officer
Nicholas N. Vahanian
President & Director